Cyclohexanaminium (2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl phosphate

Catalog No. :
ACBUVG501
CAS No. :
51306-17-3
Molecular Formula :
C18H39N2O9P
Molecular Weight :
458.49

IUPAC Name:cyclohexanamine hemi((2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl phosphate)

Cyclohexanaminium (2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl phosphate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameCyclohexanaminium (2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl phosphate
IUPAC Namecyclohexanamine hemi((2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl phosphate)
Molecular FormulaC18H39N2O9P
Molecular Weight458.49
SMILESNC1CCCCC1.NC2CCCCC2.O[C@@H]3[C@H](O[C@@H]([C@H]([C@@H]3O)O)CO)OP(O)(O)=O
InChI KeyYBPDNWXTAIIEAM-SHPZNGBNSA-N
Synonymα-d(+)mannose 1-phosphate bis(cyclohexylammonium) salt;α-d-mannopyranosyl phosphate;a-D-Mannose-1-phosphatebis(cyclohexylammonium)salt;α-D(+)Mannose 1-phosphate hydrate sodium salt;ALPHA-D-MANNOPYRANOSYL PHOSPHATE DI(MONOCYCLOHEXYLAMMONIUM) SALT;ALPHA-D(+)MANNOSE 1-PHOSPHATE DI(MONOCYCLOHEXYLAMMONIUM) SALT;A-D-plus-mannose 1-phosphate*di-monocyclohexylamm;A-D-PLUS-MANNOSE 1-PHOSPHATE*DI-MONOCYCL OHEXYLAMMON
CAS No.51306-17-3

Synthetic Route by SureRoute

1. ACBUVG501 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBUVG501 route product structure diagram
    ACBUVG50151306-17-3
Inquiry

2. ACBUVG501 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBUVG501 route product structure diagram
    ACBUVG50151306-17-3
Inquiry

Comments (0)